The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population

por Plonis, J, Kalniete, D, Nakazawa-Miklasevica, M, Irmejs, A, Vjaters, E, Gardovskis, J, Miklasevics, E
Publicado 2016

Von Hippel-Lindau Syndrome: Diagnosis and Management of Hemangioblastoma and Pheochromocytoma

por Vaganovs, P., Bokums, K., Miklaševics, E., Plonis, J., Zarina, L., Geldners, I., Gardovskis, J., Vjaters, E.
Publicado 2013